Company Summary
Search
Home Page
 
PharmaGap Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31SuspendN
Board of Directors
NamePosition
Daniel Larkin  Director of the Board
Ian Malone  Director of the Board
Jenny Phipps  Director of the Board
Not Applicable (None)  President
Robert Letellier  Director of the Board
Roderick M. Bryden  Chairperson of the Board
  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
4/Feb/1997  Canada Alberta  
Exchange Filing Office
Location
NEX Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Biotechnology Research and Development Laboratories or Services  Biotechnology company focused on designing novel cancer drugs. 
Securities
SymbolSecurity NameMarketStatus
GAP.HPharmaGap Inc.TSX VentureSUSPEND
Name HistoryFromTo
PharmaGap Inc.23/Apr/2002Present
Company Facts Reconciliation
SubjectDate Returned
Fall 2014 CFR4/Nov/2014
Associations
Auditing Firm:  KPMG
Law Firm:  Perley-Robertson, Hill & McDougall LLP
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  19/Aug/2013  NEWS RELEASE - ASC CTO RE PHARMAGAP INC.[MARKET NEWS]
    NEWS RELEASE - OSC ISSUER CEASE TRADE ORDER FOR PHARMAGAP INC.[MARKET NEWS]
    NEWS RELEASE - OSC RE PHARMAGAP INC. NOTICE OF ORDER[MARKET NEWS]
Bulletins  8/May/2013  Remain Suspended
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data